Vaccinex plans Nasdaq exit as Alzheimer market pressure grows

Following equity shortcomings, Vaccinex ends its journey as a public company after six and a half…

Novo Nordisk (NVO) Sinks after Weight-Loss Drug Trial Misses Expectations – TipRanks

Novo Nordisk (NVO) Sinks after Weight-Loss Drug Trial Misses Expectations  TipRanks

38 attorneys general urge FDA to offer protection from fake weight loss drugs – Santa Clarita Valley Signal

38 attorneys general urge FDA to offer protection from fake weight loss drugs  Santa Clarita Valley Signal

Reality star, 45, reveals 100lb weight loss thanks to Ozempic… see what she looks like now – Daily Mail

Reality star, 45, reveals 100lb weight loss thanks to Ozempic… see what she looks like now  Daily…

Reality star, 45, reveals 100lb weight loss thanks to Ozempic… see what she looks like now – Daily Mail

Reality star, 45, reveals 100lb weight loss thanks to Ozempic… see what she looks like now  Daily…

Eli Lilly’s first weight-loss pill could expand access to GLP-1s around the globe, executive says – Quartz

Eli Lilly’s first weight-loss pill could expand access to GLP-1s around the globe, executive says  Quartz

New Molecule Competes with Ozempic, Showing Fewer Side Effects – DISCOVER Magazine

New Molecule Competes with Ozempic, Showing Fewer Side Effects  DISCOVER Magazine

Novo Nordisk Shares Tumble 8% on CagriSema Weight Loss Miss – GuruFocus.com

Novo Nordisk Shares Tumble 8% on CagriSema Weight Loss Miss  GuruFocus.com

Judge Denies Injunction for Copycats of Lilly’s Weight Loss Drug – Bloomberg Law

Judge Denies Injunction for Copycats of Lilly’s Weight Loss Drug  Bloomberg Law

Novo Nordisk’s Next-Gen Obesity Drug Disappoints Again With Lower Than Expected Weight Loss – MedCity News

Novo Nordisk’s Next-Gen Obesity Drug Disappoints Again With Lower Than Expected Weight Loss  MedCity News